World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
84
Citations
29963
World Ranking
909
National Ranking
420

Overview

Cornelius J. Clancy is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on fields related to medicine, with particular emphasis on infectious diseases and epidemiology. Their body of work spans interdisciplinary areas including biochemistry, genetics, molecular biology, applied microbiology and biotechnology, molecular medicine, and clinical biochemistry.

The scientist has contributed extensively to the study of antimicrobial resistance, with key topics of their research including antifungal resistance and susceptibility, antibiotic use and resistance, antibiotic resistance in bacteria, bacterial identification and susceptibility testing, fungal infections and studies, antibiotics pharmacokinetics and efficacy, and Pneumocystis jirovecii pneumonia detection and treatment.

Frequent co-authors collaborating with Cornelius J. Clancy include:

  • M. Hong Nguyen
  • Shaoji Cheng
  • Deanna J. Buehrle
  • Ryan K. Shields

Publication venues where Cornelius J. Clancy has frequently published are:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Intensive Care Medicine

Among recent publications authored or co-authored by Cornelius J. Clancy are:

  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections, 2023, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections, 2021, Clinical Infectious Diseases
  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2022, Clinical Infectious Diseases
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion, 2020, Intensive Care Medicine
  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2020, Clinical Infectious Diseases

Best Publications

  • Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

    Cornelius J. Clancy;M. Hong Nguyen

  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

    Unknown

  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.

    Unknown

  • Pharmacokinetic/Pharmacodynamic Profile of Posaconazole

    Ursula Theuretzbacher;Franziska Ihle;Hartmut Derendorf

  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

    Unknown

  • Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.

    Ryan K. Shields;M. Hong Nguyen;Liang Chen;Ellen G. Press

  • Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

    Ryan K. Shields;Liang Chen;Shaoji Cheng;Kalyan D. Chavda

  • T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial

    Eleftherios Mylonakis;Cornelius J. Clancy;Luis Ostrosky-Zeichner;Kevin W. Garey

  • Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections.

    Ryan K. Shields;Brian A. Potoski;Ghady Haidar;Binghua Hao

  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and <i>Pseudomonas aeruginosa</i> with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)

    Unknown

  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

    Paul E. Verweij;Bart J.A. Rijnders;Roger J.M. Brüggemann;Elie Azoulay

  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

    Pranita D Tamma;Samuel L Aitken;Robert A Bonomo;Amy J Mathers

  • Performance of Candida Real-time Polymerase Chain Reaction, β-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

    M. Hong Nguyen;Mark C. Wissel;Ryan K. Shields;Martin A. Salomoni

  • Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with Candida Fungemia

    M. Hong Nguyen;Cornelius J. Clancy;Victor L. Yu;Yue C. Yu

  • Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.

    Ryan K. Shields;M. Hong Nguyen;Liang Chen;Ellen G. Press

  • Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect?

    Cornelius J Clancy;M Hong Nguyen

  • Diagnosing Invasive Candidiasis

    Cornelius J. Clancy;M. Hong Nguyen

  • Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

    Ghady Haidar;Nathan J Philips;Ryan K Shields;Daniel Snyder

  • Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.

    WB Grow;JS Moreb;D Roque;K Manion

  • Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

    Cornelius J. Clancy;Reia A. Jaber;Helen L. Leather;John R. Wingard

  • Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia

    Cornelius J. Clancy;Victor L. Yu;Arthur J. Morris;David R. Snydman

  • Candida albicans Pathogenesis: Fitting Within the “Host-Microbe Damage Response Framework”

    Mary Ann Jabra-Rizk;Eric F. Kong;Christina Tsui;M. Hong Nguyen

Frequent Co-Authors

M. Hong Nguyen
M. Hong Nguyen University of Pittsburgh
Ryan K. Shields
Ryan K. Shields University of Pittsburgh
Joseph M. Pilewski
Joseph M. Pilewski University of Pittsburgh
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation
Liang Chen
Liang Chen Hackensack Meridian Health Center for Discovery and Innovation
Yohei Doi
Yohei Doi University of Pittsburgh
John R. Wingard
John R. Wingard University of Florida
Marilyn M. Wagener
Marilyn M. Wagener University of Pittsburgh
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
A. William Pasculle
A. William Pasculle University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Health information management is one such field that blends healthcare and data expertise. Understanding the health information management salary and career paths can help gauge the potential benefits of entering this growing sector.

When considering degrees, it’s important to choose programs with recognized accreditation. The best online health information management degree cahiim accredited programs ensure quality education aligned with industry standards, improving job prospects and readiness.

For those seeking shorter credential pathways, accelerated courses like the medical billing and coding certificate online accelerated programs offer quick entry into the healthcare administration workforce. These certifications complement scientific backgrounds such as microbiology by broadening skill sets.

Additionally, many students explore online medical degrees that offer flexibility and accessibility. With the rise of digital learning, combining microbiology knowledge with healthcare-focused online degrees can lead to impactful careers in research, diagnostics, and health informatics.

Best Scientists Citing Cornelius J. Clancy

Trending Scientists